Skip to main content
PMC home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1983 Oct;80(19):5871–5874. doi: 10.1073/pnas.80.19.5871

Bis-penicillamine enkephalins possess highly improved specificity toward delta opioid receptors.

H I Mosberg, R Hurst, V J Hruby, K Gee, H I Yamamura, J J Galligan, T F Burks
PMCID: PMC390177  PMID: 6310598

Abstract

The conformationally restricted, cyclic, disulfide-containing, enkephalin analogs [2-D-penicillamine, 5-L-penicillamine]enkephalin [(D-Pen2,L-Pen5]enkephalin) and [2-D-penicillamine, 5-D-penicillamine]enkephalin [(D-Pen2,D-Pen5]enkephalin) were synthesized by solid-phase methods. Selectivities of these analogs for a single class of opioid receptor were investigated by examining relative potencies in the mouse vas deferens assay, in which the functional receptor is the delta receptor, versus the guinea pig ileum assay, in which the mu receptor is the functional receptor, and by determining their relative abilities to displace the prototypical delta receptor ligand [D-Ala2, D-Leu5]enkephalin and the prototypical mu receptor ligand naloxone from rat brain membrane preparations. Based on these comparisons [D-Pen2,L-Pen5]- and [D-Pen2,D-Pen5]enkephalin exhibited delta receptor selectivities of 1,088 and 3,164, respectively, in the bioassays, and 371 and 175, respectively, in the binding assays. Compared with the previously reported delta receptor selective analogs, [D-Ala2,D-Leu5]enkephalin, [D-Ser2,Leu5,Thr6]enkephalin, and [D-Thr2,Leu5,Thr6]enkephalin, the bis-Pen-containing analogs provide an order of magnitude increase in delta receptor selectivity.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chang K. J., Cuatrecasas P. Multiple opiate receptors. Enkephalins and morphine bind to receptors of different specificity. J Biol Chem. 1979 Apr 25;254(8):2610–2618. [PubMed] [Google Scholar]
  2. DiMaio J., Nguyen T. M., Lemieux C., Schiller P. W. Synthesis and pharmacological characterization in vitro of cyclic enkephalin analogues: effect of conformational constraints on opiate receptor selectivity. J Med Chem. 1982 Dec;25(12):1432–1438. doi: 10.1021/jm00354a008. [DOI] [PubMed] [Google Scholar]
  3. DiMaio J., Schiller P. W. A cyclic enkephalin analog with high in vitro opiate activity. Proc Natl Acad Sci U S A. 1980 Dec;77(12):7162–7166. doi: 10.1073/pnas.77.12.7162. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Fournie-Zaluski M. C., Gacel G., Maigret B., Premilat S., Roques B. P. Structural requirements for specific recognition of mu or delta opiate receptors. Mol Pharmacol. 1981 Nov;20(3):484–491. [PubMed] [Google Scholar]
  5. Gacel G., Fournie-Zaluski M. C., Roques B. P. D-Tyr--Ser-Gly--Phe--Leu--Thr, a highly preferential ligand for delta-opiate receptors. FEBS Lett. 1980 Sep 8;118(2):245–247. doi: 10.1016/0014-5793(80)80229-8. [DOI] [PubMed] [Google Scholar]
  6. Gillan M. G., Kosterlitz H. W., Paterson S. J. Comparison of the binding characteristics of tritiated opiates and opioid peptides. Br J Pharmacol. 1980 Nov;70(3):481–490. doi: 10.1111/j.1476-5381.1980.tb08727.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Gillan M. G., Kosterlitz H. W. Spectrum of the mu, delta- and kappa-binding sites in homogenates of rat brain. Br J Pharmacol. 1982 Nov;77(3):461–469. doi: 10.1111/j.1476-5381.1982.tb09319.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Handa B. K., Land A. C., Lord J. A., Morgan B. A., Rance M. J., Smith C. F. Analogues of beta-LPH61-64 possessing selective agonist activity at mu-opiate receptors. Eur J Pharmacol. 1981 Apr 9;70(4):531–540. doi: 10.1016/0014-2999(81)90364-2. [DOI] [PubMed] [Google Scholar]
  9. Hughes J., Kosterlitz H. W., Leslie F. M. Effect of morphine on adrenergic transmission in the mouse vas deferens. Assessment of agonist and antogonist potencies of narcotic analgesics. Br J Pharmacol. 1975 Mar;53(3):371–381. doi: 10.1111/j.1476-5381.1975.tb07373.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Jones C. R., Gibbons W. A., Garsky V. Proton magnetic resonance studies of conformation and flexibility of enkephalin peptides. Nature. 1976 Aug 26;262(5571):779–782. doi: 10.1038/262779a0. [DOI] [PubMed] [Google Scholar]
  11. Khaled M. A., Long M. M., Thompson W. D., Bradley R. J., Brown G. B., Urry D. W. Conformational states of enkephalins in solution. Biochem Biophys Res Commun. 1976 May 23;76(2):224–231. doi: 10.1016/0006-291x(77)90715-x. [DOI] [PubMed] [Google Scholar]
  12. Kosterlitz H. W., Lord J. A., Paterson S. J., Waterfield A. A. Effects of changes in the structure of enkephalins and of narcotic analgesic drugs on their interactions with mu- and delta-receptors. Br J Pharmacol. 1980 Feb;68(2):333–342. doi: 10.1111/j.1476-5381.1980.tb10422.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Kosterlitz H. W., Lydon R. J., Watt A. J. The effects of adrenaline, noradrenaline and isoprenaline on inhibitory alpha- and beta-adrenoceptors in the longitudinal muscle of the guinea-pig ileum. Br J Pharmacol. 1970 Jun;39(2):398–413. doi: 10.1111/j.1476-5381.1970.tb12903.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Lord J. A., Waterfield A. A., Hughes J., Kosterlitz H. W. Endogenous opioid peptides: multiple agonists and receptors. Nature. 1977 Jun 9;267(5611):495–499. doi: 10.1038/267495a0. [DOI] [PubMed] [Google Scholar]
  15. Meraldi J. P., Hruby V. J., Brewster A. I. Relative conformational rigidity in oxytocin and (1-penicillamine)-oxytocin: a proposal for the relationship of conformational flexibility to peptide hormone agonism and antagonism. Proc Natl Acad Sci U S A. 1977 Apr;74(4):1373–1377. doi: 10.1073/pnas.74.4.1373. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Mosberg H. I., Hruby V. J., Meraldi J. P. Conformational study of the potent peptide hormone antagonist [1-penicillamine,2-leucine]oxytocin in aqueous solution. Biochemistry. 1981 May 12;20(10):2822–2828. doi: 10.1021/bi00513a018. [DOI] [PubMed] [Google Scholar]
  17. Mosberg H. I., Hurst R., Hruby V. J., Galligan J. J., Burks T. F., Gee K., Yamamura H. I. Conformationally constrained cyclic enkephalin analogs with pronounced delta opioid receptor agonist selectivity. Life Sci. 1983 May 30;32(22):2565–2569. doi: 10.1016/0024-3205(83)90239-4. [DOI] [PubMed] [Google Scholar]
  18. Mosberg H. I., Hurst R., Hruby V. J., Galligan J. J., Burks T. F., Gee K., Yamamura H. I. [D-Pen2, L-Cys5]enkephalinamide and[D-Pen2, D-Cys5] enkephalinamide, conformationally constrained cyclic enkephalinamide analogs with delta receptor specificity. Biochem Biophys Res Commun. 1982 May 31;106(2):506–512. doi: 10.1016/0006-291x(82)91139-1. [DOI] [PubMed] [Google Scholar]
  19. Piercey M. F., Lahti R. A., Schroeder L. A., Einspahr F. J., Barsuhn C. U-50488H, a pure kappa receptor agonist with spinal analgesic loci in the mouse. Life Sci. 1982 Sep 20;31(12-13):1197–1200. doi: 10.1016/0024-3205(82)90341-1. [DOI] [PubMed] [Google Scholar]
  20. Roques B. P., Garbay-Jaureguiberry C., Oberlin R., Anteunis M., Lala A. K. Conformation of Met5-enkephalin determined by high field PMR spectroscopy. Nature. 1976 Aug 26;262(5571):778–779. doi: 10.1038/262778a0. [DOI] [PubMed] [Google Scholar]
  21. Schiller P. W., Eggimann B., DiMaio J., Lemieux C., Nguyen T. M. Cyclic enkephalin analogs containing a cystine bridge. Biochem Biophys Res Commun. 1981 Jul 30;101(2):337–343. doi: 10.1016/0006-291x(81)91265-1. [DOI] [PubMed] [Google Scholar]
  22. Shimohigashi Y., Costa T., Chen H. C., Rodbard D. Dimeric tetrapeptide enkephalins display extraordinary selectivity for the delta opiate receptor. Nature. 1982 May 27;297(5864):333–335. doi: 10.1038/297333a0. [DOI] [PubMed] [Google Scholar]
  23. Wolozin B. L., Pasternak G. W. Classification of multiple morphine and enkephalin binding sites in the central nervous system. Proc Natl Acad Sci U S A. 1981 Oct;78(10):6181–6185. doi: 10.1073/pnas.78.10.6181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Zajac J. M., Gacel G., Petit F., Dodey P., Rossignol P., Roques B. P. Deltakephalin, Tyr-D-Thr-Gly-Phe-Leu-Thr: a new highly potent and fully specific agonist for opiate delta-receptors. Biochem Biophys Res Commun. 1983 Mar 16;111(2):390–397. doi: 10.1016/0006-291x(83)90318-2. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES